AAPL   373.89 (+2.69%)
MSFT   210.42 (+2.02%)
FB   238.67 (+2.25%)
GOOGL   1,501.61 (+2.16%)
AMZN   3,009.00 (+4.11%)
NVDA   394.61 (+2.63%)
CGC   16.80 (+2.13%)
BABA   238.26 (+6.56%)
MU   50.91 (+2.17%)
GE   6.91 (+1.32%)
TSLA   1,323.69 (+9.52%)
AMD   53.18 (+1.59%)
T   30.28 (+0.67%)
ACB   12.29 (+0.16%)
F   6.14 (+1.32%)
GILD   77.05 (+0.92%)
DIS   113.46 (+1.14%)
BAC   23.48 (+0.82%)
NFLX   497.50 (+4.32%)
BA   182.02 (+0.67%)
AAPL   373.89 (+2.69%)
MSFT   210.42 (+2.02%)
FB   238.67 (+2.25%)
GOOGL   1,501.61 (+2.16%)
AMZN   3,009.00 (+4.11%)
NVDA   394.61 (+2.63%)
CGC   16.80 (+2.13%)
BABA   238.26 (+6.56%)
MU   50.91 (+2.17%)
GE   6.91 (+1.32%)
TSLA   1,323.69 (+9.52%)
AMD   53.18 (+1.59%)
T   30.28 (+0.67%)
ACB   12.29 (+0.16%)
F   6.14 (+1.32%)
GILD   77.05 (+0.92%)
DIS   113.46 (+1.14%)
BAC   23.48 (+0.82%)
NFLX   497.50 (+4.32%)
BA   182.02 (+0.67%)
AAPL   373.89 (+2.69%)
MSFT   210.42 (+2.02%)
FB   238.67 (+2.25%)
GOOGL   1,501.61 (+2.16%)
AMZN   3,009.00 (+4.11%)
NVDA   394.61 (+2.63%)
CGC   16.80 (+2.13%)
BABA   238.26 (+6.56%)
MU   50.91 (+2.17%)
GE   6.91 (+1.32%)
TSLA   1,323.69 (+9.52%)
AMD   53.18 (+1.59%)
T   30.28 (+0.67%)
ACB   12.29 (+0.16%)
F   6.14 (+1.32%)
GILD   77.05 (+0.92%)
DIS   113.46 (+1.14%)
BAC   23.48 (+0.82%)
NFLX   497.50 (+4.32%)
BA   182.02 (+0.67%)
AAPL   373.89 (+2.69%)
MSFT   210.42 (+2.02%)
FB   238.67 (+2.25%)
GOOGL   1,501.61 (+2.16%)
AMZN   3,009.00 (+4.11%)
NVDA   394.61 (+2.63%)
CGC   16.80 (+2.13%)
BABA   238.26 (+6.56%)
MU   50.91 (+2.17%)
GE   6.91 (+1.32%)
TSLA   1,323.69 (+9.52%)
AMD   53.18 (+1.59%)
T   30.28 (+0.67%)
ACB   12.29 (+0.16%)
F   6.14 (+1.32%)
GILD   77.05 (+0.92%)
DIS   113.46 (+1.14%)
BAC   23.48 (+0.82%)
NFLX   497.50 (+4.32%)
BA   182.02 (+0.67%)
Log in

ASX:COHCochlear Stock Price, Forecast & News

A$190.98
+2.31 (+1.22 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$184.18
Now: A$190.98
A$190.98
50-Day Range
A$190.98
MA: A$190.98
A$190.98
52-Week Range
A$154.60
Now: A$190.98
A$254.40
Volume201,277 shs
Average Volume194,422 shs
Market Capitalization$12.54 billion
P/E Ratio36.07
Dividend Yield1.94%
BetaN/A
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company has strategic collaborations with Sensorion and GN Hearing A/S to focus on improving hearing outcomes in patients with cochlear implants. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia.
Read More
Cochlear logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-2-94286555

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.48 billion
Cash FlowA$1.55 per share
Book ValueA$13.95 per share

Profitability

Miscellaneous

Employees3,500
Market Cap$12.54 billion
Next Earnings Date8/19/2020 (Estimated)
OptionableOptionable

Receive COH News and Ratings via Email

Sign-up to receive the latest news and ratings for COH and its competitors with MarketBeat's FREE daily newsletter.

Cochlear (ASX:COH) Frequently Asked Questions

How has Cochlear's stock been impacted by COVID-19 (Coronavirus)?

Cochlear's stock was trading at A$189.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, COH shares have increased by 1.0% and is now trading at A$190.98. View which stocks have been most impacted by Coronavirus.

When is Cochlear's next earnings date?

Cochlear is scheduled to release its next quarterly earnings announcement on Wednesday, August 19th 2020. View our earnings forecast for Cochlear.

How were Cochlear's earnings last quarter?

Cochlear Limited (ASX:COH) issued its quarterly earnings data on Tuesday, February, 19th. The company reported $2.15 EPS for the quarter, missing the Zacks' consensus estimate of $2.19 by $0.04. View Cochlear's earnings history.

How often does Cochlear pay dividends? What is the dividend yield for Cochlear?

Cochlear announced a Interim dividend on Wednesday, February 19th. Stockholders of record on Friday, April 17th will be paid a dividend of 1.60 per share on Friday, April 17th. This represents a dividend yield of 0.64%. The ex-dividend date of this dividend is Tuesday, March 24th. This is an increase from Cochlear's previous Interim dividend of A$1.55. View Cochlear's dividend history.

Has Cochlear been receiving favorable news coverage?

News coverage about COH stock has been trending negative recently, according to InfoTrie. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cochlear earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about Cochlear.

Who are some of Cochlear's key competitors?

What other stocks do shareholders of Cochlear own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares S&P 500 ETF (IVV), CSL (CSL), ResMed (RMD), Rio Tinto (RIO), Altium (ALU), Abbott Laboratories (ABT), Afterpay Touch Group (APT), Appen (APX), Alumina (AWC) and Cross Timbers Royalty Trust (CRT).

Who are Cochlear's key executives?

Cochlear's management team includes the following people:
  • Mr. Diggory William Howitt, CEO, MD, Pres & Exec. Director (Age 52)
  • Mr. Brent Andrew Cubis, Chief Financial Officer
  • Mr. Jan Janssen, Chief Technology Officer
  • Mr. Richard Brook, Pres of EMEA & Latin American Region
  • Mr. Anthony Manna, Pres of Americas Region

What is Cochlear's stock symbol?

Cochlear trades on the ASX under the ticker symbol "COH."

What is Cochlear's stock price today?

One share of COH stock can currently be purchased for approximately A$190.98.

How big of a company is Cochlear?

Cochlear has a market capitalization of $12.54 billion and generates $1.48 billion in revenue each year. Cochlear employs 3,500 workers across the globe.

What is Cochlear's official website?

The official website for Cochlear is www.cochlear.com.

How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555.

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.